New biomarker for onchocerciasis
A newly identified biomarker detectable in urine could prove useful in developing a portable field test for onchocerciasis or river blindness. Using a painstaking process of metabolomic data mining the researchers were able to identify a metabolite that occurred in the urine from onchocerciasisinfected patients but not in health controls. The metabolite, N-acetyltyramine-O,β-glucuronide, could be traced to O. volvulus as a neurotransmitter molecule that is secreted by young, reproducing worms and then modified by the human body on its way to being excreted in urine. This biomarker appears to be specific for an active infection, suggesting that a field test based on the biomarker would be robustly useful. The next goal would be to create a simple and inexpensive urine dipstick test that is tolerant of extreme temperatures and portable. Current diagnostic methods include biopsies for microscopic analysis, and an ELISA antibody test for microfilariae, which may yield positive results even for non-active infections.
Globisch et al. Proceedings of the National Academy of Sciences, “Onchocerca volvulus Neurotransmitter Tyramine is a Biomarker for River Blindness,†2013 110 (11) 4218-4223.Â
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.